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doi:10.1016/j.asjsur.2012.04.006Summary Background: Fournier gangrene is a necrotizing fasciitis, arising in the genital and
perineal area. This entity is still associated with a high mortality rate despite improvements in
antibiotic and surgical treatment.
Methods: This is a retrospective study of all the patients diagnosed and surgically treated for
Fournier gangrene at General University Hospital Ramon y Cajal between 1988 and 2008.
Possible prognostic factors that could have any influence on the evolution of Fournier gangrene
were analyzed.
Results: Seventy patients were analyzed, 62 males (88.6%) and 8 females (11.4%) with a mean
age of 57.9  13.5 years. Most frequent clinical manifestations were perineal pain (82.9%) and
fever (60%). Physical examination revealed edema (91.4%), erythema (88.6%) and perineal skin
necrosis (60%). All the patients underwent surgical debridement of necrotic tissue. In 54.3% re-
operations were necessary for new surgical debridements. Medical complications rate was
27.1% and mortality one 22.9%. Ethylism, coexistence of neoplasms, presence of skin necrosis,
myonecrosis, abdominal wall affection, number of debrided areas, reoperations, concentra-
tion of creatinine in serum>1.4 mg/dL, and hemoglobin <10 g/dL, and platelet count
<150  109/L in whole blood are associated with higher mortality rates.
Conclusion: Identification of prognostic factors may help to determine high-risk patients in
order to establish an optimal treatment, according to severity of the infection and general
status.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.Maria, 64, 7J, 28002 Madrid, Spain.
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Table 1 Personal history.
Global Survivors Nonsurvivors p
n (%) n (%) n (%)
Diabetes mellitus 39 (55.7) 34 (63) 5 (40) NS
Hematological
disorders
10 (14.3) 6 (11.1) 4 (25) NS
Hepatopathy 8 (11.4) 4 (7.4) 4 (25) NS
Ethilism 6 (8.6) 2 (3.7) 4 (25) 0.045
Neoplasms 6 (8.6) 2 (3.7) 4 (25) 0.045
Recent surgery 4 (5.7) 4 (7.4) 0 NS
Morbid obesity 4 (5.7) 2 (7.4) 2 (12.5) NS
NS Z nonsignificant.
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Fournier gangrene is a form of necrotizing fasciitis, arising
in the genital and perineal area, that may extend through
fascial layer to the groin, thigh and even abdominal wall.
Infection leads to thrombosis of subcutaneous blood
vessels, which is the main cause of the overlaying skin
necrosis. Fournier gangrene begins with local tenderness,
edema, and erythema of the scrotal and perianal skin. This
progresses to necrosis of the scrotal fascia. The scrotum
enlarges to several times its normal diameter. If the process
continues beyond the penile-scrotal region to the abdomen
or the upper legs, the normal picture of necrotizing fasciitis
can be seen. Necrotizing fasciitis is defined as a progres-
sive, rapidly spreading, inflammatory infection located in
the deep fascia, with secondary necrosis of the subcuta-
neous tissue.1,2
Diverse microorganisms (Gram-positive and Gram-
negative bacteria, anaerobic bacteria, and fungi) are
involved in the infection. Actually, this entity is still asso-
ciated with a high mortality rate despite the improvement
of antibiotic and surgical treatment.1,3
Diverse factors have been established as poor outcome
predictors, such as advanced age, comorbidities (diabetes
mellitus, alcoholism, cachexia), delayed diagnosis and
treatment, extension of the gangrene developing a necro-
tizing fasciitis, reoperations and some laboratory data at
diagnosis (low hematocrit and albumin concentration, and
high creatinine and alkaline phosphatase).2,3 The aim of
this study is to analyze possible prognostic factors that
could influence on the evolution of Fournier gangrene,
reviewing our experience in the management of this entity
during the last 20 years.
2. Patients and methods
This is a retrospective study of all the patients diagnosed of
Fournier gangrene and undergoing surgical treatment at
University Hospital Ramon y Cajal, Madrid, Spain from 1988
to 2008. Age, gender, personal history, clinical manifesta-
tions and exploratory findings, laboratory data, microbio-
logical cultures, surgical procedure, infection origin, depth
affection, reoperations, debrided anatomical areas, post-
operative complications, mortality, hospital stay, and
follow-up were investigated.
Inclusion criteria for the diagnosis of Fournier gangrene
were the appearance of local tenderness, edema, and
erythema arising initially in the genital or perianal area,
independently of the posterior progression of the infection
to the abdomen or upper legs, developing a necrotizing
fasciitis. Exclusion criteria were the development of these
signs and symptoms in the genital and perianal area as
continuation of a primary infectious process located in
another site.
Statistic analysis was performed with SPSS 14.0 for
Windows. Quantitative variables following a normal distri-
butionweredefinedbymean, standarddeviation, and range.
In non-Gaussian variables,medianwas used instead ofmean.
Qualitative variables were defined by number of cases and
percentage. Quantitative and qualitative variables were
compared with the Student t method (or Mann-Whitneymethod when quantitative variables did not follow
Gaussian distribution). Qualitative variables were compared
with Chi-square method. A p-value < 0.05 was considered
significant.3. Results
Seventy patients were analyzed, 62 males (88.6%) and 8
females (11.4%) with a mean age of 57.9  13.5 years
(range 22e84 years). Relevant personal history data are
summarized in Table 1.
Diabetes mellitus coexisted in 39 patients (55.7%).
Haematological disorders were AIDS in five patients (7.1%),
chronic myeloid leukemia in one (1.4%), and pancytopenia
secondary to myelodysplastic syndrome in one. Eight
patients (11.4%) presented hepatic disorders, five (7.1%) of
them secondary to hepatitis C and three (4.3%) to alco-
holism. Two patients (2.8%) presented prostatic neoplasms;
in the other four with previous diagnosis of cancer, these
were located in larynx, lung, right colon and bladder. Two
subjects (2.8%) presented a recent surgical antecedent:
prostatic adenomectomy and transurethral resection of
a bladder tumor.
The most frequent clinical manifestations were perineal
pain (n Z 58, 82.9%) and fever (n Z 42, 60%). Median
evolution time of the symptoms up to medical examination
was 7 days (range 2e30 days). Physical examination
revealed edema (n Z 64, 91.4%), erythema (n Z 62, 8.6%)
and perineal skin necrosis (n Z 42, 60%); regional crepita-
tion was discovered in 22 patients (31.4%).
Laboratory data are described in Table 2. The origin of
the gangrene was located in the perineal area in 64 patients
(91.4%) and in the urological tract in 6 (8.6%). Depth of
infection was limited to skin and subcutaneous tissue in 40
patients (57.1%), in 24 patients (34.3%) the fascia was
overcome, developing a necrotizing fasciitis, and in six
(8.6%) muscle necrosis (myonecrosis) was evident. All the
patients underwent surgical debridements of necrotic
tissue. In eight patients (11.4%) fecal diversion had pro-
ceeded, in six because of sphincterian myonecrosis, and
two cases due to iatrogenic rectal perforation. Debrided
areas are explained in Table 3. In 38 patients (54.3%)
reoperations were necessary for new surgical debride-
ments; in four patients (5.6%) two reoperations were per-
formed, one patient underwent three and another one
Table 2 Laboratory data.
Global Survivors Nonsurvivors p
White blood cells ( /mm3) 16428  8634 17478  8880 10915  4734 NS
Hemoglobin (g/dl) 11.9  2.4 12.5  2.2 9.2  1.5 0.01
Platelets ( /ml) 2277330  149156 271667  146553 95933  41321 0.007
Creatinine (mg/dl) 1.21  0.45 1.1  0.3 2.1  0.7 0.001
Urea (mg/dl) 61.4  17.5 63.7  19.2 52  11.4 NS
BUN (mg/100 ml) 26.6  7.8 27.4  9.4 24.2  8.1 NS
GOT (U/L) 16.7  11.6 10  1 30  4.2 NS
GPT (U/L) 11.7  7.4 7.5  2.1 20  5.4 NS
Bilirubin (mg/dl) 0.7  0.5 0.5  0.4 0.8  0.2 NS
Alkaline phosphatase (U/L) 217.5  236.9 285  202.1 150  240.2 NS
Glucose (mg/dl) 273.3  124.7 279.4  128.9 217.5  78.5 NS
Prothrombin time (seconds) 17.3  9.2 19  10.4 12.1  6 NS
Cephalin time (seconds) 39.8  12 38.8  14.8 41.5  7.8 NS
Fibrinogen (mg/dl) 848.8  251.1 883.2  210.2 688.2  412.3 NS
Results are defined in mean  standard deviation.
NS Z nonsignificant.
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bad aspect of the wound with purulent segregation or
necrotic tissue, progression to necrotizing fasciitis and
septic status. In five patients with septic status and wound
and perilesional tissues with apparently good evolution,
a pelvic computed tomography scan was performed to
evaluate deep tissue affection, revealing a pelvic abscess in
two cases.
After surgery, wide-spectrum antibiotic treatment was
started in all the patients. The drugs employed have changed
over the years; in the first decade of the studied period,
amoxicillin/clavulanic acid was mostly used (1 g/8 h), but in
the last decade imipenem and meropenem (1 g/8 h) were
widely employed. Patients presenting allergies to beta-
lactamic agents were mostly treated with gentamycin
240 mg/24 h and metronidazole (500 mg/8 h).
Medical complications were seen in 19 patients (27.1%):
14 nosocomial pneumonias, three central line catheter
infections, and two urinary infections; all were satisfacto-
rily managed with antibiotic treatment. Mortality rate was
22.9% (16 patients). All the deceased cases were caused by
septic shock and multiorganic failure, related to an
uncontrolled extension of the necrotizing fasciitis despiteTable 3 Debrided areas.
Global Survivors Nonsurvivors p
n (%) n (%) n (%)
Perianal 52 (74.3) 38 (70.4) 14 (87.5) NS
Scrotum 46 (65.7) 32 (59.3) 14 (87.5) NS
Perineum 42 (60) 30 (55.6) 12 (75) NS
Groin 28 (40) 20 (37) 8 (50) NS
Thigh 14 (20) 10 (18.5) 4 (25) NS
Abdominal wall 10 (14.3) 4 (7.4) 6 (37.5) 0.033
Lumbar region 2 (2.9) 2 (3.7) 0 NS
Number of debrided regions: median 3 (range 1-6).
NS Z nonsignificant.correct surgical debridements. Dividing the sample into 2
groups depending on the date of diagnosis (1988e1998 and
1999e2008), there were no significant differences among
mortality (23.1% vs. 22.8%).
During the follow-up, 5 patients (7.1%) were diagnosed
with anorectal tumors at 1, 2, 4, 6, and 8 months after
Fournier gangrene.
Evaluating prognostic factors, it was observed that
alcoholism, coexistence of neoplasms, presence of skin
necrosis, myonecrosis, abdominal wall affection, number of
debrided areas, reoperations, serum creatinin, hemoglobin
levels, and platelet count were associated with higher
mortality. Cut points were established for significant labo-
ratory data in creatinine > 1.4 mg/dL, hemoglobin < 10
g/dL, and platelets < 150  109/L. The results of the
statistical analysis are in Table 4.4. Discussion
Fournier gangrene is a surgical emergency with a high
mortality rate despite adequate treatment.3Although
antimicrobial drugs have undergone important advances in
recent decades, with the appearance of new and stronger
agents with wide spectrum, the main treatment of Fournier
gangrene remains surgical debridement. In our series we
have observed that the mortality rate was similar among
the patients diagnosed in the first decade to those diag-
nosed in the second, despite the use of newer drugs in the
last 10 years of the study. In some recent publications,
mortality associated with this pathology is estimated
around 20% to 35%.2,4 Similar to other entities, better
results are related to an early diagnosis and adequate
surgical treatment.1,3,4 Unfortunately, early diagnosis does
not depend on physicians in most cases, thus the patients
consult usually in advanced phases, leading these to rapid
progression of the infection and development of a necro-
tizing fasciitis. Median evolution time up to medical eval-
uation in our series was 7 days. Notwithstanding,
identification of prognostic factors could have some
Table 4 Factors associated to mortality.
Odds ratio (95%CI) p
Ethylism 8.7 (1.6 e 112) 0.045
Neoplasms 8.7 (1.6 e 112) 0.045
Skin necrosis 1.4 (1.06 e 1.95) 0.05
Mionecrosis 9.6 (1.12 e 98.7) 0.04
Abdominal wall affection 7.5 (1.2 e 57.2) 0.033
Number of debrided areas > 4 8.7 (1.7 e 102.3) 0.043
Need for reoperations 1.7 (1.2 e 2.5) 0.004
Creatinine > 1.4 mg/dL 2 (1.3 e 5.3) 0.009
Hemoglobin < 10 g/dL 9.6 (1.3 e 73) 0.008
Platelets < 150  109/L 6 ((1.4 e 44.9) 0.018
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treatment to the personal situation of each patient.
Older patients and those with comorbidities, such as
diabetes mellitus, alcoholism or cachexia, are considered
to present worse prognosis. Similarly, patients with a longer
period up to the treatment, with wider extension of the
infection or those requiring a colostomy are associated with
worse outcome. A low socioeconomical level has also been
described as a poor prognostic factor.2,6
In our series we could not demonstrate advanced age to
be associated with higher mortality, the mean age of our
patients being 57.9 years, similar to those described in
other recent studies.3 Diabetes mellitus is the most
frequent comorbidity among our patients (55.7%), but its
association with higher mortality could not be demon-
strated, as described by other authors.7 In the same way,
glucose levels at diagnosis in our patients were not associ-
ated with higher mortality.
Referring to alcoholism and coexistence of neoplasms,
we found an association with higher mortality rate (odds
ratio [OR] 8.7, 95% confidence interval [95%CI] 1.6-112) in
both groups, as described by other authors.8
The extension of the infection is one of the most
important prognostic factors in Fournier gangrene.4,9 In our
study, we have divided the affected surface into areas, as
explained in Table 3. When 4 or more regions are affected,
survival is significantly worse (OR 8.7, 95%CI 1.7e102.3).
Reoperations are also associated with the number of
affected areas (p Z 0.011). The extension of the infection
to the abdominal wall has been a bad prognostic factor in
our study, independently of the number of affected areas
(OR 7.5, 95%CI 1.2e57.2). Myonecrosis was also associated
with higher mortality (OR 9.6, 95%CI 1.12e98.7), as
described in the literature.5 Moreover, we have observed
that patients with skin necrosis at the time of diagnosis
presented worse outcome (OR 1.4 95%CI 1.06 e 1.95).
Those patients undergoing reoperations presented
a higher mortality risk, because these are usually necessary
when infections progress and develop necrotizing fasciitis
despite initial debridements, revealing extremely aggres-
sive features.10 Other authors have reported that there is
no relationship between the number of reoperations and
mortality rate,11 in contrast to what occurred in our
patients.
Referring to laboratory data, low hematocrit and
albumin concentration, and increased creatinine and
alkaline phosphatase have been associated with a highermortality rate. In our series we have established cut points;
when creatinine values are over 1.4 mg/dL, mortality
is twice (95%CI 1.3e5.3), hemoglobin levels lower than
10 g/dL present a risk 9.6-fold higher (95%CI 1.3e73) and
when platelets count is <150  109/L the risk of decease is
6-fold higher (95%CI 1.4e44.9). Increased creatinine levels
reflect renal dysfunction, probably related to septic shock
and may be the initial stage of a multiorgan failure.
Reduced hemoglobin levels show the worsening of the
general status, also related with sepsis originated from
Fournier gangrene; on the other hand it facilitates the
appearance of postoperative complications. Platelet count
has not been described as a bad prognostic factor, but it is
probably associated with the reduction of hemoglobin
levels, also related with the initial septic status.2,12,13
In the literature, the best prognostic tool to evaluate the
severity of Fournier gangrene is the Fournier Gangrene
Severity Index Score, which assigns a numerical score
describing the acuity of the disease. This index describes
patients’ vital signs (temperature, heart and respiratory
rates) and metabolic parameters (sodium, potassium,
creatinine, and bicarbonate concentrations, hematocrit,
white blood cell count) and computes a score relating to
the severity of the disease at that time.4 One of the main
limitations of our study is that we could not apply this
Index, because our study is a long-term retrospective series
and unfortunately some data were not available in the
clinical history, mainly nonrecorded patient vital signs and
some analytical parameters.
Based on the results of this study, we suggest that when
facing patients with risk factors, a more aggressive treat-
ment (surgical and antibiotic) should be started from the
beginning and a careful follow-up (frequent clinical exam-
ination of the surgical site, blood analysis and eventual
imaging tests when considered necessary) during the post-
operative period must be performed, in order to achieve
early detection of any possible complication.
5. Conclusion
Fournier gangrene is a surgical emergency, associated with
a high mortality rate despite adequate surgical debride-
ment and wide spectrum antibiotherapy. Identification of
prognostic factors may help to determine patients with
higher mortality risk and to establish an optimal treatment,
according to severity of the infection and general status.
We have established alcoholism, coexistence of neoplasms,
presence of skin necrosis, mionecrosis, gangrene extension,
abdominal wall affection, reoperations and laboratory data
(creatinine > 1.4 mg/dL, hemoglobin < 10 g/dL,
platelets < 150  109/L) as prognostic factors associated
with higher mortality.References
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